Mercaptobenzimidazole ligand modified gold nanoparticles as well as preparation method and application thereof

The preparation of gold nanoparticles modified with thiol benzimidazole ligands by one-pot method solves the problem of poor control of traditional antibacterial materials on a variety of bacterial infections, and achieves efficient and stable antibacterial effects, which are suitable for industrial applications.

CN118976897APending Publication Date: 2024-11-19WUHAN UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410909223.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-08
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The abuse of existing antibiotics has led to increased bacterial resistance, and traditional antibacterial materials are difficult to effectively control multiple bacterial infections, especially ‘super bacteria’. The development of new antibacterial materials has become an urgent need.

Method used

Gold nanoparticles modified with thiol benzimidazole ligands were prepared by one-pot method, and chemical modification of thiol benzimidazole and gold was used to form efficient antibacterial materials. By controlling reaction conditions and parameters, uniform and stable gold nanoparticles were prepared. , used to prepare antibacterial materials that are antibacterial against E. coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus.

Benefits of technology

The inhibition rate of more than 99.99% for a variety of bacteria is achieved, and the broad-spectrum and efficient antibacterial properties are demonstrated. The preparation process is simplified and the material is stable, which is suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976897A_ABST
    Figure CN118976897A_ABST
Patent Text Reader

Abstract

The invention discloses gold nanoparticles modified by sulfydryl benzimidazole ligands as well as a preparation method and application of the gold nanoparticles, and belongs to the technical field of nano materials. The preparation method comprises the following steps: step 1, adding a sulfydryl benzimidazole compound into a reaction system containing an organic solvent, and stirring to dissolve the sulfydryl benzimidazole compound; 2, adding a chloroauric acid trihydrate solution into a reaction solution in the step 1, and stirring to react for a period of time; 3, adding a sodium borohydride solution into a reaction solution in the step 2, and continuously stirring to react for a period of time; and 4, after the reaction is finished, the gold nanoparticles are obtained through the steps of rotary evaporation, dissolution, alkaline water drop precipitation, centrifugation and freeze drying. The sulfydryl benzimidazole ligand modified gold nanoparticles with excellent performance are prepared through a one-pot method, the preparation process is simplified, the antibacterial performance and stability of the nanoparticles are improved, and a new thought and method are provided for research and application of antibacterial materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of nanomaterials, and specifically relates to a gold nanoparticle modified with a mercaptobenzimidazole ligand, and a preparation method and application thereof. Background Art

[0002] Bacterial infection is one of the top ten leading causes of death in the world, with more than 10 million people dying from bacterial infection each year. Solving the problem of bacterial infection is an urgent priority in the current global health field. Since the advent of penicillin in 1942, antibiotics have become the main force in treating bacterial infections. With the development of science and technology, the types and performance of antibiotics have been greatly improved. Antibiotics are undoubtedly the best "executioners" to kill bacteria, safe, cheap, and industrially produced. Humans seem to be completely free from the crisis of bacterial infection. However, this is not the case. In the past 20 years, the abuse of antibiotics has become more and more serious, and bacterial resistance has also increased significantly, and many "super bacteria" have emerged. The mutation rate of bacteria is much faster than the update rate of antibiotics. It is no longer feasible to control bacterial infections only through antibiotics. Therefore, the development of new antibacterial materials is a top priority.

[0003] The rapid development of nanotechnology has provided a new idea for fighting bacterial infections. In the past two decades, nanotechnology has achieved great success in fighting bacterial infections, and many nanomaterials have been shown to have excellent antibacterial properties. These nano antibacterial materials mainly include four categories, namely carbon-based nanomaterials, boride nanomaterials, polymer nanomaterials and metal-based nanomaterials. These nanomaterials exert their antibacterial effects by affecting the integrity of bacterial cell membranes, releasing antibacterial metal ions, generating reactive oxygen species (ROS) and inhibiting enzyme activity. Among the many nanomaterials, gold nanomaterials are widely used as antibacterial and antiviral drugs due to their high antipathogen activity and biocompatibility. In addition to the good biocompatibility of gold itself, gold nanomaterials can be controlled by chemical methods to maximize their antibacterial effects, such as size, shape, and surface composition. In addition, studies have shown that gold nanomaterials have a low frequency of inducing bacterial resistance.

[0004] Benzimidazole is an important class of biologically active heterocyclic compounds. Its electron-rich nitrogen heterocyclic ring can easily accept or donate protons and easily form various forms of weak interactions, which provides advantages for its binding to therapeutic targets and exhibits a wide range of pharmacological activities. Many reports have confirmed that benzimidazole and its derivatives have extremely high potential in the treatment of autoimmune\inflammatory diseases, metabolic disorders (obesity), neurological diseases, microbial diseases, cancer, respiratory diseases, cardiovascular diseases and other diseases. Summary of the invention

[0005] In view of the deficiencies in the prior art, the purpose of the present invention is to provide a mercaptobenzimidazole ligand-modified gold nanoparticle and a preparation method and application thereof. The present invention prepares a mercaptobenzimidazole ligand-modified gold nanoparticle with excellent performance by a one-pot method, which not only simplifies the preparation process, but also improves the antibacterial performance and stability of the nanoparticles, providing a new idea and method for the research and application of antibacterial materials.

[0006] To achieve the above object, the present invention is implemented by the following technical solutions:

[0007] The present invention provides a method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands, comprising:

[0008] Step 1: Add a mercaptobenzimidazole compound to a reaction system containing an organic solvent and stir to dissolve;

[0009] Step 2: Add chloroauric acid solution to the reaction solution in step 1, and stir to react for a period of time;

[0010] Step 3: Add the sodium borohydride solution to the reaction solution of step 2, and continue to stir and react for a period of time;

[0011] Step 4: After the reaction is completed, the gold nanoparticles are obtained through rotary evaporation, dissolution, alkaline water precipitation, centrifugation and freeze drying steps.

[0012] The reaction mechanism of the above scheme is: first, the mercaptobenzimidazole ligand is mixed with gold, and the trivalent gold is reduced to a monovalent gold complex through the mercapto group in the ligand, and then sodium borohydride is added to reduce the monovalent gold complex to zero-valent gold, and then the product is treated and purified to obtain gold nanoparticles.

[0013] Preferably, in step 1, the organic solvent is a mixed solvent containing methanol and acetic acid.

[0014] In the above scheme, the mixed solvent of methanol and acetic acid can not only effectively dissolve the mercaptobenzimidazole compounds, but also promote the reduction reaction of gold ions, which is beneficial to the formation of stable gold nanoparticles.

[0015] Further preferably, the volume ratio of methanol to acetic acid is (12-14):(3-4).

[0016] In the above scheme, the optimized solvent ratio can further improve the reaction efficiency and product stability. The appropriate solvent ratio helps to maintain the uniformity of the reaction system and reduce the occurrence of side reactions, thereby obtaining purer and more uniform gold nanoparticles.

[0017] Preferably, the mercaptobenzimidazole compound includes 5-methoxy-2-mercaptobenzimidazole; the molar ratio of the chloroauric acid to the 5-methoxy-2-mercaptobenzimidazole is 1:8-10; and the molar ratio of the chloroauric acid to the sodium borohydride is 1:50-70.

[0018] Preferably, the solvent in the chloroauric acid solution is methanol, and the solvent in the sodium borohydride solution is ethanol.

[0019] Preferably, in step 2, the stirring speed is 600-1000 rpm, and the reaction time is 30-40 min.

[0020] In the above scheme, the appropriate stirring speed and reaction time in step 2 can ensure sufficient contact and reaction between the reactants, promote the reduction of gold ions and the formation of nanoparticles. At the same time, a reasonable reaction time can avoid the occurrence of excessive reduction or aggregation, and ensure the quality and stability of the product.

[0021] Preferably, in step 3, the stirring speed is 1200-1500 rpm, and the reaction time is 60-90 min.

[0022] In the above scheme, after the sodium borohydride solution is added in step 3, increasing the stirring speed and extending the reaction time are helpful to further promote the reduction reaction of gold ions and stabilize the size and morphology of the nanoparticles.

[0023] Preferably, step 4 specifically includes: after the reaction is completed, pouring the sample into a flask for rotary evaporation, dissolving the product after rotary evaporation with methanol, and using alkaline water with a pH of 9-10 for drop precipitation, setting the centrifuge speed to 6000-7000rpm, the time is 10-15min, repeating three times, collecting the sample, and freeze-drying to obtain the gold nanoparticles.

[0024] In the above scheme, through post-treatment steps such as rotary evaporation, dissolution, alkaline water precipitation, centrifugation and freeze drying, impurities and unreacted products in the reaction system can be effectively removed, thereby improving the purity and stability of the product.

[0025] The invention also provides a mercaptobenzimidazole ligand-modified gold nanoparticle, which is prepared by the preparation method.

[0026] The present invention also provides an application of the gold nanoparticles modified with mercaptobenzimidazole ligands in the preparation of antibacterial materials.

[0027] Preferably, the antibacterial material is an antibacterial material that is resistant to Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus.

[0028] In the above scheme, the antibacterial material prepared by using the gold nanoparticles has a broad-spectrum and highly effective antibacterial property, and can effectively inhibit a variety of bacteria (such as Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus). This antibacterial material has important application value in the fields of medical treatment and health.

[0029] The invention also provides an antibacterial material, comprising the gold nanoparticles as an effective antibacterial component.

[0030] In the above scheme, the antibacterial material uses gold nanoparticles as the effective antibacterial component, combines the excellent performance of gold nanoparticles and the chemical modification of mercaptobenzimidazole ligands, and has the advantages of high efficiency, stability, and non-toxicity. This antibacterial material can maintain the antibacterial effect for a long time in practical applications and reduce the risk of bacterial contamination.

[0031] Compared with the prior art, the present invention has the following beneficial effects:

[0032] (1) The present invention prepares a type of mercaptobenzimidazole ligand-modified gold nanoparticles by a one-pot method. The entire preparation process has clear steps, a simple and convenient preparation process, does not require complex equipment or conditions, and is easy to promote and apply in industry.

[0033] (2) The present invention precisely controls the reaction conditions and parameters (such as the molar ratio of 5-methoxy-2-mercaptobenzimidazole, chloroauric acid and sodium borohydride, reaction time and reaction solvent) to prepare gold nanoparticles with a size of about 2 nm and good uniformity, which is of great significance for the performance and application of nanomaterials.

[0034] (3) The gold nanoparticles prepared by the present invention can be uniformly and stably dispersed in solvents such as dimethyl sulfoxide (DMSO) and are not prone to aggregation or precipitation, which is beneficial for their application in antibacterial materials.

[0035] (4) The gold nanoparticles prepared by the present invention exhibit an inhibition rate of more than 99.99% against a variety of bacteria, including Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus, showing broad-spectrum and high-efficiency antibacterial properties. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 This is a transmission electron microscope image of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0037] Figure 2 This is a statistical diagram of the particle size distribution of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0038] Figure 3This is the full X-ray photoelectron spectrum of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0039] Figure 4 This is the gold subdivision spectrum of the X-ray photoelectron spectrum of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0040] Figure 5 This is the ultraviolet absorption spectrum of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0041] Figure 6 This is the infrared absorption spectrum of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0042] Figure 7 The storage days of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole in Example 1.

[0043] Figure 8 This is an application example of the antibacterial data image of 5-methoxy-2-mercaptobenzimidazole-modified gold nanoparticles used in Escherichia coli and Staphylococcus aureus.

[0044] Fig. 9 This is the antibacterial data image of 5-methoxy-2-mercaptobenzimidazole-modified gold nanoparticles used in the application example for methicillin-resistant Staphylococcus aureus. DETAILED DESCRIPTION

[0045] In order to enable those skilled in the art to better understand the technical solution of the present invention, the preferred implementation scheme of the present invention is described below in conjunction with specific embodiments, but it should not be understood as limiting the present invention and is only used as an example.

[0046] The experimental methods or test methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials are obtained from conventional commercial channels or prepared by conventional methods unless otherwise specified.

[0047] Example 1

[0048] This embodiment provides a method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands, comprising:

[0049] Preparation of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole (MMB): A 50 mL round-bottom flask was fixed on a constant temperature heated magnetic stirrer, a clean magnet was placed, the stirring speed was set to 600 rpm, and 13 mL of methanol and 3.5 mL of acetic acid were added to the flask. 100 mg of 5-methoxy-2-mercaptobenzimidazole was weighed with an electronic balance and added to the round-bottom flask, and stirred for 5 min until completely dissolved. 1.24 mL of 50 mM chloroauric acid trihydrate solution (HAuCl4·3H2O methanol phase) was added to the solution, the stirring speed was 600 rpm, the solution changed from colorless to orange-yellow, and the reaction lasted for 30 min. 142 mg of sodium borohydride (NaPH4) was weighed with an electronic balance and dissolved in 4 mL of ethanol, the sodium borohydride solution was added to the reaction solution, the stirring speed was set to 1200 rpm, the solution changed from orange-yellow to brown, and the reaction lasted for 90 min. After the reaction, the sample was poured into a 250 mL flask and rotary evaporated. The product after rotary evaporation was dissolved in methanol and precipitated with alkaline water (PH = 10), the centrifuge speed was set to 6500 rpm, the time was 10 min, and repeated three times, the sample was collected, and freeze-dried to obtain 5-methoxy-2-mercaptobenzimidazole modified gold nanoparticles (MMB-AuNPs).

[0050] Example 2

[0051] This embodiment provides a method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands, comprising:

[0052] Preparation of gold nanoparticles modified with methoxy-2-mercaptobenzimidazole (MMB): A 50 mL round-bottom flask was fixed on a constant temperature heated magnetic stirrer, a clean magnet was placed, the stirring speed was set to 800 rpm, and 12 mL of methanol and 3 mL of acetic acid were added to the flask. 89 mg of 5-methoxy-2-mercaptobenzimidazole was weighed with an electronic balance and added to the round-bottom flask, and stirred for 5 min until completely dissolved. 1.24 mL of 50 mM chloroauric acid trihydrate solution (HAuCl4·3H2O methanol phase) was added to the solution, the stirring speed was 800 rpm, the solution changed from colorless to orange-yellow, and the reaction lasted for 35 min. 117 mg of sodium borohydride (NaPH4) was weighed with an electronic balance and dissolved in 4 mL of ethanol, the sodium borohydride solution was added to the reaction solution, the stirring speed was set to 1300 rpm, the solution changed from orange-yellow to brown, and the reaction lasted for 60 min. After the reaction, the sample was poured into a 250 mL flask and rotary evaporated. The product after rotary evaporation was dissolved in methanol and precipitated with alkaline water (PH = 9), the centrifuge speed was set to 6000 rpm, the time was 10 min, and repeated three times, the sample was collected, and freeze-dried to obtain 5-methoxy-2-mercaptobenzimidazole modified gold nanoparticles (MMB-AuNPs).

[0053] Example 3

[0054] This embodiment provides a method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands, comprising:

[0055] Preparation of gold nanoparticles modified with methoxy-2-mercaptobenzimidazole (MMB): A 50 mL round-bottom flask was fixed on a constant temperature heated magnetic stirrer, a clean magnet was placed, the stirring speed was set to 1000 rpm, and 14 mL of methanol and 4 mL of acetic acid were added to the flask. 112 mg of 5-methoxy-2-mercaptobenzimidazole was weighed with an electronic balance and added to the round-bottom flask, and stirred for 5 min until completely dissolved. 1.24 mL of 50 mM chloroauric acid trihydrate solution (HAuCl4·3H2O methanol phase) was added to the solution, the stirring speed was 1000 rpm, the solution changed from colorless to orange-yellow, and the reaction was carried out for 40 min. 164 mg of sodium borohydride (NaPH4) was weighed with an electronic balance and dissolved in 4 mL of ethanol, the sodium borohydride solution was added to the reaction solution, the stirring speed was set to 1500 rpm, the solution changed from orange-yellow to brown, and the reaction was carried out for 80 min. After the reaction, the sample was poured into a 250 mL flask and rotary evaporated. The product after rotary evaporation was dissolved in methanol and precipitated with alkaline water (PH = 10), the centrifuge speed was set to 7000 rpm, the time was 10 min, and repeated three times, the sample was collected, and freeze-dried to obtain 5-methoxy-2-mercaptobenzimidazole modified gold nanoparticles (MMB-AuNPs).

[0056] The present invention is described by taking the gold nanoparticles (MMB-AuNPs) prepared in Example 1 as an example:

[0057] Figure 1 Transmission electron microscopy image of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole, showing that the size of MMB-AuNPs is less than 3 nm and has good dispersion without large-scale aggregation.

[0058] Figure 2 The particle size distribution statistics of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole are obtained by selecting Figure 1 The particle size of 50 gold nanoparticles was analyzed and statistically analyzed. The analysis found that the particle size of MMB-AuNPs was about 2.0nm, which conforms to the Gaussian distribution.

[0059] Figure 3 This is the full X-ray photoelectron spectrum of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole, which proves that MMB-AuNPs contain five elements: Au, C, N, O, and S.

[0060] Figure 4This is the gold breakdown spectrum of the X-ray photoelectron spectrum of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole. This figure proves that MMB-AuNPs contain both zero-valent gold and one-valent gold, which is consistent with the structure of gold nanoparticles.

[0061] Figure 5 This is the ultraviolet absorption spectrum of the gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole of Example 1 of the present invention, which reflects the ultraviolet-visible light absorption of MMB-AuNPs. Its ultraviolet absorption in the wavelength range of 350 to 600 nm is significantly enhanced, corresponding to the characteristic absorption of gold nanoparticles, and an obvious absorption peak appears at 310 nm, corresponding to the structural characteristic peak of the benzimidazole ring.

[0062] Figure 6 This is the infrared absorption spectrum of gold nanoparticles modified with 5-methoxy-2-mercaptobenzimidazole. The spectrum shows that the thiol stretching vibration peak at 2565 of MMB-AuNPs disappears, proving that the ligand MMB is anchored on the surface of gold nanoparticles through Au-S bonds.

[0063] Figure 7 The figure shows that MB-AuNPs, whether in solution or solid powder, still have good antibacterial properties after being stored at -4°C for 5 months, indicating that they have good stability.

[0064] Application Examples

[0065] The gold nanoparticles prepared in Example 1 were used as antibacterial materials, and their antibacterial properties were tested as follows:

[0066] Preparation: Weigh 5 mg of LB broth (powder) in a conical flask, add 200 mL of water and ultrasonically dissolve to prepare LB medium, then sterilize in an autoclave at 120°C for 20 min. Weigh 16 mg of LB nutrient agar, add 400 μL of water, ultrasonically dissolve, autoclave at 120°C for 20 min, pour into a sterile culture dish, 20 mL per dish, and cool to obtain solid agar medium. Resuscitate the strain and subculture twice, and culture until the exponential growth phase (OD 600nm =1), dilute the bacteria 10000 times to 2×10 5 CFU / mL for later use.

[0067] 100 μL of LB medium was first added to each well of the 96-well plate, and then 100 μL of gold nanoparticle material (512 μg mL -1 ), and logarithmically dilute each row with a pipette, adding 100 μL of diluted bacterial solution (the final bacterial solution concentration was 1×105 CFU / mL). Place the 96-well plate in a constant temperature incubator and culture at 37°C for 12 h. Take 10 μL of the treated bacterial solution and dilute it with LB medium to 1×10 6 Times, take 100 μL of the diluted solution and drop it on the surface of the solid agar culture medium, spread it evenly with a glass rod, and turn it upside down (to prevent contamination) when there is no flowing liquid on the surface. Put the treated culture dish in a constant temperature incubator at 37°C and culture it for 12 hours, and take a picture of the culture dish.

[0068] The above antibacterial performance test method is also applicable to the antibacterial test of Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus.

[0069] Figure 8 The data image of 5-methoxy-2-mercaptobenzimidazole-modified gold nanoparticles for the antibacterial effect on Escherichia coli and Staphylococcus aureus. The culture dish in the upper left corner of the picture is a control group of pure Escherichia coli, and many Escherichia coli colonies grow on the LB plate. The upper right corner of the picture is a plate after MMB-AuNPs and Escherichia coli are co-incubated. It can be seen that there are no obvious colonies, proving that it has a strong killing power against Escherichia coli; similarly, the lower left corner of the picture is a control group of pure Staphylococcus aureus, and many Staphylococcus aureus colonies grow on the LB plate, while the plate in the lower right corner of the picture after MMB-AuNPs and Staphylococcus aureus are co-incubated. No obvious colonies are seen, proving that it also has a strong killing power against Staphylococcus aureus.

[0070] Fig. 9 The data image of the antibacterial effect of 5-methoxy-2-mercaptobenzimidazole-modified gold nanoparticles on methicillin-resistant Staphylococcus aureus. The left picture is the control group of pure methicillin-resistant Staphylococcus aureus. Many colonies of methicillin-resistant Staphylococcus aureus grew on the LB plate. The right picture is the plate after MMB-AuNPs and methicillin-resistant Staphylococcus aureus were co-incubated. It can be seen that there are no obvious colonies, proving that it has a strong killing power against methicillin-resistant Staphylococcus aureus.

[0071] The above are only preferred embodiments of the present invention. It should be noted that the above preferred embodiments should not be regarded as limiting the present invention, and the protection scope of the present invention should be based on the scope defined by the claims. For ordinary technicians in this technical field, several improvements and modifications can be made without departing from the spirit and scope of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention.

Claims

1. A method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands, characterized in that: include: Step 1: Add a mercaptobenzimidazole compound to a reaction system containing an organic solvent and stir to dissolve; Step 2: Add chloroauric acid solution to the reaction solution in step 1, and stir to react for a period of time; Step 3: Add the sodium borohydride solution to the reaction solution of step 2, and continue to stir and react for a period of time; Step 4: After the reaction is completed, the gold nanoparticles are obtained through rotary evaporation, dissolution, alkaline water precipitation, centrifugation and freeze drying steps.

2. The method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands according to claim 1, characterized in that: In step 1, the organic solvent is a mixed solvent containing methanol and acetic acid.

3. The method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands according to claim 2, characterized in that: The volume ratio of methanol to acetic acid is (12-14):(3-4).

4. The method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands according to claim 1, characterized in that: The mercaptobenzimidazole compound includes 5-methoxy-2-mercaptobenzimidazole; the molar ratio of the chloroauric acid to the 5-methoxy-2-mercaptobenzimidazole is 1:8-10; the molar ratio of the chloroauric acid to the sodium borohydride is 1:50-70.

5. The method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands according to claim 1, characterized in that: In step 2, the stirring speed is 600-1000 rpm, and the reaction time is 30-40 min.

6. The method for preparing gold nanoparticles modified with mercaptobenzimidazole ligands according to claim 1, characterized in that: In step 3, the stirring speed is 1200-1500 rpm, and the reaction time is 60-90 min.

7. A gold nanoparticle modified with a mercaptobenzimidazole ligand, characterized in that: The gold nanoparticles are prepared by the preparation method according to any one of claims 1 to 6.

8. Use of the gold nanoparticles modified with mercaptobenzimidazole ligands as claimed in claim 7 in the preparation of antibacterial materials.

9. The use according to claim 8, characterized in that: The antibacterial material is an antibacterial material that is resistant to Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus.

10. An antibacterial material, characterized in that: The gold nanoparticles according to claim 7 are contained as an effective antibacterial component.